Sprucegrove Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,310
Closed -$1.67M 42
2025
Q2
$1.67M Sell
13,310
-800
-6% -$99.7K 0.14% 32
2025
Q1
$1.93M Sell
14,110
-83,745
-86% -$12M 0.21% 30
2024
Q4
$15M Hold
97,855
1.07% 22
2024
Q3
$19M Sell
97,855
-200
-0.2% -$41.8K 1.06% 21
2024
Q2
$22.7M Buy
98,055
+1,200
+1% +$261K 1.18% 15
2024
Q1
$20.9M Buy
96,855
+34,100
+54% +$7.99M 0.84% 21
2023
Q4
$16.2M Buy
62,755
+800
+1% +$196K 0.7% 16
2023
Q3
$15.9M Buy
61,955
+1,943
+3% +$520K 1% 13
2023
Q2
$17.1M Sell
60,012
-11,388
-16% -$3.39M 0.89% 14
2023
Q1
$19.9M Buy
71,400
+2,700
+4% +$747K 1.08% 13
2022
Q4
$19M Sell
68,700
-27,800
-29% -$7.85M 1.05% 16
2022
Q3
$25.8M Sell
96,500
-73,000
-43% -$15.5M 1.48% 11
2022
Q2
$34.6M Sell
169,500
-94,700
-36% -$19.4M 1.72% 16
2022
Q1
$55.6M Sell
264,200
-59,300
-18% -$12.9M 1.79% 21
2021
Q4
$77.6M Buy
323,500
+89,500
+38% +$23M 1.96% 21
2021
Q3
$66.2M Buy
234,000
+33,600
+17% +$11M 1.63% 22
2021
Q2
$69.4M Buy
200,400
+96,900
+94% +$29.4M 1.64% 21
2021
Q1
$29M Buy
+103,500
New +$27.9M 0.71% 32

Other funds holding BIIB

Sprucegrove Investment Management's BIIB Position: Q3 2025 in Review

Sprucegrove Investment Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 13,310 shares — an estimated $1.67M sold.

Sprucegrove Investment Management first reported a position in BIIB in Q1 2021 and held it in 18 quarters. The position peaked at $77.6M in Q4 2021. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Sprucegrove Investment Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Sprucegrove Investment Management sold 13,310 Biogen shares in Q3 2025, an estimated $1.67M.
  • Sprucegrove Investment Management first reported a position in Biogen in Q1 2021 and held it in 18 quarters.
  • Sprucegrove Investment Management's Biogen position peaked at $77.6M in Q4 2021.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Sprucegrove Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.